GLP-1 coverage in North Carolina
Documented Medicaid fee-for-service status and insurance-mandate activity — not a decision for your member ID.
Sources last checked October 28, 2026
Spot an error? Report a correction
Medicaid (obesity / weight-loss)
KFF, "Medicaid Coverage of and Spending on GLP-1s", January 2026
This is the KFF January 2026 fee-for-service survey row for North Carolina. Managed-care plans in the same state can differ. GLP-1s prescribed for type 2 diabetes are covered by every state Medicaid program regardless of this row.
North Carolina temporarily dropped coverage in October 2025 and reinstated it in December 2025 — its current status above reflects January 2026.
NC Medicaid reinstated coverage of GLP-1 drugs for obesity on December 12, 2025.
NC Medicaid coverage for GLP-1s for the treatment of obesity was reinstated effective December 12, 2025. Wegovy is a Preferred Product. Zepbound and Saxenda are Non-Preferred, and members must try and fail Wegovy or have a documented reason.
Source: NC Medicaid: Reinstitute coverage of GLP-1s for weight management, 2025-12-19
Prior authorization requests for GLP-1 weight management drugs can be submitted under the reinstated criteria, which are the criteria in place as of September 30, 2025 (NC Medicaid Outpatient Pharmacy Prior Approval Criteria, GLP-1s for Weight Management, effective August 1, 2024).
Source: NC Medicaid: Reinstitute coverage of GLP-1s for weight management, 2025-12-19
Earlier, NC Medicaid announced that obesity coverage for Wegovy, Zepbound and Saxenda would end on October 1, 2025, citing shortfalls in state funding. Prior authorizations ended after September 30, 2025.
Source: NC Medicaid: Change in coverage of GLP-1s for weight management, 2025-09-05
KFF's survey of state Medicaid officials reports that North Carolina dropped GLP-1 obesity coverage in October 2025 and restored it in December 2025.
Source: KFF: Medicaid Coverage of and Spending on GLP-1s, 2026-01-16
The most recent NC Medicaid notice we found is dated December 19, 2025. Check NC Medicaid for later changes.
Source: NC Medicaid: Reinstitute coverage of GLP-1s for weight management, 2025-12-19
Diabetes
NC Medicaid said there would be no changes to coverage of GLP-1 medications for the treatment of diabetes. Wegovy and Zepbound also remain covered for other FDA-approved uses: cardiovascular risk reduction and MASH for Wegovy, and obstructive sleep apnea in adults with obesity for Zepbound.
Source: NC Medicaid: Change in coverage of GLP-1s for weight management, 2025-09-05
State insurance-mandate activity
No mandate activity found in our current tracking for North Carolina. That is not a denial — in most cases your employer plan matters more than a state statute. Full list: state laws.
What to do with this
Medicaid survey rows and mandate bills are not a prior-authorization approval. Call the number on your ID card and ask whether the drug is covered for your diagnosis.
Full 5-step checklist →Related: All state pages · Medicaid by state · State laws · Cash-pay options